RDGTHealthcare · Pharmaceutical RetailersTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 22 of 100 as at 1 Aug 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores China Jo-Jo Drugstores, Inc. /Old/ on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (100): Smaller than most of the companies we track.
Value (1): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own China Jo-Jo Drugstores, Inc. /Old/ — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on RDGT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 71% of US stocks
Cheaper than 99% of US stocks
Cheaper than 92% of US stocks
Cheaper than 36% of US stocks
Higher than 14% of US stocks
Higher than 59% of US stocks
Higher than 18% of US stocks
Higher than 35% of US stocks
Higher than 71% of US stocks
Higher than 37% of US stocks
Higher than 39% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| RDGTChina Jo-Jo Drugstores, Inc. /Old/ | $2.7M | 22 |
| NUWENuwellis, Inc.* | $633,900.00 | 24 |
| ELOXEloxx Pharmaceuticals, Inc.* | $731,000.00 | 16 |
| SCNXScienture Holdings, Inc. | $15.5M | 11 |
| PFSAProfusa, Inc.* | $561,800.00 | 8 |
| BJDXBluejay Diagnostics, Inc.* | $889,900.00 | 21 |
| VTAKCatheter Precision, Inc.* | $906,000.00 | 28 |
* Nearest Healthcare names by size — few pharmaceutical retailers companies of this scale trade in the US universe.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. RDGT appears on the weeks it earns a place.
Ridgetech, Inc. (Nasdaq: RDGT) reported its financial results for the fiscal year ended March 31, 2026. The company completed its strategic transition to a wholesale-focused business model.
Why it matters — This is the first look at Ridgetech's financial performance after completing its strategic shift to a wholesale-only model, giving shareholders a baseline for evaluating the new business direction.
Ridgetech Inc. announced that its wholly owned subsidiary, Zhejiang Jiuxin Medicine Co., Ltd., has been elected as a vice-president unit of the Hangzhou Qiantang District Biomedical and Cosmetic High-Quality Development Association, which is set to be officially inaugurated on July 28, 2026.
Why it matters — The vice-president role signals Ridgetech's growing influence and recognition within the regional biomedical industry, which could strengthen its wholesale pharmaceutical distribution business.
As at 1 Aug 2026, China Jo-Jo Drugstores, Inc. /Old/ ranks 22 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (100 of 100).
No analyst covering China Jo-Jo Drugstores, Inc. /Old/ publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RDGT are extrapolating price history, which says nothing about the business.
China Jo-Jo Drugstores, Inc. /Old/ returned -99.5% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Ridgetech, Inc. is a healthcare company specializing in the retail and distribution of pharmaceutical and related healthcare products.
The most recent item we track (PRNewsWire, 31 July 2026): "Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results". Ridgetech, Inc. (Nasdaq: RDGT) reported its financial results for the fiscal year ended March 31, 2026. The company completed its strategic transition to a wholesale-focused business model.
Ridgetech, Inc. is a healthcare company specializing in the retail and distribution of pharmaceutical and related healthcare products. Headquartered in Hangzhou, China, the firm operates through several distinct business segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its retail drugstores offer a wide selection of prescription and over-the-counter medications, nutritional supplements, medical devices, traditional Chinese medicines (TCM), and various consumer healthcare and daily-use items. The company’s online pharmacy segment strengthens its digital reach, selling healthcare products through third-party e-commerce platforms as well as its proprietary website. The wholesale division supplies both its own stores and external clients, including hospitals and other drug vendors, with a broad portfolio of pharmaceutical products. An additional herb farming segment focuses on cultivating herbs for use in TCM and wider distribution. Serving as both a retailer and distributor, Ridgetech, Inc. plays an important role in China’s healthcare supply chain, connecting manufacturers with retail and institutional consumers while supporting both offline and online channels in the growing medical distribution sector.
CEO Mr. Ming Zhao · 61 employees · China · https://www.ridgetch.com